Divestiture

Private equity firm Clairvest Group reports a 9% book value surge, driven by lucrative sales of F12.net and Acera, while acquiring a major US racino.

With the hire of elite dealmaker George F. Schoen, the building materials giant is signaling a new era of aggressive M&A and strategic consolidation.

Iveco Group shareholders will decide the fate of its defence unit: a €1.7B sale to Leonardo with a huge dividend, or a spin-off into a new public company.

With its Q4 and full-year 2025 earnings release imminent, Ingevity faces investor scrutiny over its recent strategic divestitures and market position.

Bio-Techne promotes Steve Crouse to lead its high-growth Diagnostics and Spatial Biology unit, signaling a strategic focus on innovation after a key divestiture.

With triple-digit growth, the firm's partner-led model is dominating the market as companies race to defend against escalating third-party cyber threats.

HeartCore Enterprises forecasts a dramatic swing to profitability in 2025 after divesting its software unit, betting its future on IPO consulting.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

After a stellar 2025, Corpay is hitting the road for key investor conferences. Can it convince the market its impressive growth is just the beginning?

Amid major restructuring and a strategic asset sale, Standard BioTools' upcoming annual results will reveal its progress toward profitability in a tough market.

Following a landmark FDA approval, IceCure Medical's long-serving CFO is exiting, placing the company at a pivotal financial crossroads for its new treatment.

A massive philanthropic gift aims to keep Hoag's nurses and staff housed in one of America's most expensive markets. Here's how it works.

Arlington Dermatology Clinic joins a national network, highlighting a major trend in healthcare consolidation. What does this mean for DFW patients?

Following a massive corruption scandal in Toronto, Ontario's Inspector General has launched a province-wide probe into police integrity and accountability.

The French mining giant is in a full-blown leadership crisis, with its CFO suspended amid an employee-triggered probe just days after its CEO was fired.

The deal marks the final step in a major strategic overhaul for dsm-firmenich, which will now focus solely on its nutrition, health, and beauty businesses.

A new subcutaneous autoinjector for Alzheimer's drug Leqembi could soon transform care for millions in China, moving treatment from hospital to home.

The legal tech firm is cleared for trading after a two-month halt, now focusing on debt reduction using proceeds from a major UK asset divestiture.

Schweiter Technologies will unveil its 2025 results and 2026 strategy on Feb 27, with investors eager for signs of growth and profitability.

Fluent sells its Winopoly subsidiary to focus on its booming Commerce Media business, a strategic pivot aiming for long-term value amid a shifting AdTech landscape.